Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rifai

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Clinical Chemistry and Laboratory Medicine|February 8, 2002
High sensitivity immunoassays for C-reactive protein: promises and pitfallsT B Ledue, N Rifai
Clinical Chemistry|October 1, 1986
Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIIIN Rifai, L M Silverman
Clinical Chemistry|March 10, 2001
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart diseaseN Rifai, P M Ridker
Clinical Chemistry and Laboratory Medicine|July 27, 1999
Inflammation, the acute phase response and atherosclerosisJ Whicher, L Biasucci, N Rifai
Clinical Chemistry|May 1, 1996
Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference MethodN Harris, V Galpchian, N Rifai
Therapeutic Drug Monitoring|October 1, 1995
Assessment of the immunoreactivity of digoxin metabolites and the cross-reactivity with digoxin-like immunoreactive factors in the Roche-TDM ONLINE digoxin assayE Bonagura, T Law, N Rifai
Atherosclerosis|February 1, 1992
Lipoprotein(a) at birth, in blacks and whitesN Rifai, G Heiss, K Doetsch
Clinics in Laboratory Medicine|June 1, 1993
Role of free radicals in cancer and atherosclerosisD D Bankson, M Kestin, N Rifai
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1992
A receptor assay for serum low density lipoprotein-apolipoprotein B-100: preliminary reportQ Pham, S J Soldin, N Rifai
Clinical Chemistry|August 22, 2001
Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assaysG R Warnick, M Nauck, N Rifai
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Clinical Chemistry and Laboratory Medicine|February 8, 2002
High sensitivity immunoassays for C-reactive protein: promises and pitfallsT B Ledue, N Rifai
Clinical Chemistry|October 1, 1986
Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIIIN Rifai, L M Silverman
Clinical Chemistry|March 10, 2001
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart diseaseN Rifai, P M Ridker
Clinical Chemistry and Laboratory Medicine|July 27, 1999
Inflammation, the acute phase response and atherosclerosisJ Whicher, L Biasucci, N Rifai
Clinical Chemistry|May 1, 1996
Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference MethodN Harris, V Galpchian, N Rifai
Therapeutic Drug Monitoring|October 1, 1995
Assessment of the immunoreactivity of digoxin metabolites and the cross-reactivity with digoxin-like immunoreactive factors in the Roche-TDM ONLINE digoxin assayE Bonagura, T Law, N Rifai
Atherosclerosis|February 1, 1992
Lipoprotein(a) at birth, in blacks and whitesN Rifai, G Heiss, K Doetsch
Clinics in Laboratory Medicine|June 1, 1993
Role of free radicals in cancer and atherosclerosisD D Bankson, M Kestin, N Rifai
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1992
A receptor assay for serum low density lipoprotein-apolipoprotein B-100: preliminary reportQ Pham, S J Soldin, N Rifai
Clinical Chemistry|August 22, 2001
Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assaysG R Warnick, M Nauck, N Rifai
Pageof 18